Willow Biosciences
(OTCQB:CANSF)
$0.0638
0[0.00%]
At close: Apr 22
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Willow Biosciences Stock (OTC:CANSF), Quotes and News Summary

Willow Biosciences Stock (OTC: CANSF) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.50.000 / 23.203K
Day Range- - -
52 Wk Range0.049 - 0.109
Market Cap$8.100M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1

Recent News

CBG Producer Willow Biosciences Announces Record 43% Revenue Increase And Strategic Moves Ahead
Willow Biosciences Inc., (OTC: CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and operational results Tuesday morning for the fourth quarter and fiscal year 2023.
Nicolás Jose Rodriguez
Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology
Biotechnology company Willow Biosciences generated around $1.3m in revenues in 2023, a 60% increase from the previous year. The company has hailed 2023 as a "transformative year," citing the launch of its BioOxi bio-oxidation platform technology as one of its top achievements. The AI-driven selective hydroxylation platform removes multiple chemical steps and reduces the cost of manufacturing target molecules. The technology has enabled Willow to accelerate its path to nearer-term and potentially larger revenue opportunities while reducing operational expenses. The company also engaged in multiple partnerships with innovators and generic pharmaceutical companies, resulting in portfolio expansion and diversification. Willow underwent a restructuring of its corporate and operational framework, including consolidating operations in the San Francisco Bay area and making changes to its leadership team. In 2024, Willow plans to capitalize on the BioOxi technology platform to bring its corticosteroids program to commercial readiness and identify strategic partners for pipeline expansion and acceleration.
Jelena Martinovic
This Precision-Fermentation Company Achieves Q3 Record Revenue And Strategic Milestones In Business Expansion
Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) has reported its financial and operating results for the third quarter ending September 30, 2023, showcasing record revenue and substantial progress in its business expansion.
Joana Scopel
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About
Sector
Healthcare
Industry
N/A
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engag...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CANSF

FAQ

Q

How do I buy Willow Biosciences (CANSF) stock?

A

You can purchase shares of Willow Biosciences (OTCQB: CANSF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Willow Biosciences's (CANSF) competitors?

A

There are no as such competitors for Willow Biosciences.

Q

What is the target price for Willow Biosciences (CANSF) stock?

A

There is no analysis for Willow Biosciences.

Q

Current Stock Price for Willow Biosciences (CANSF)?

A

The stock price for Willow Biosciences (OTCQB: CANSF) is $0.0638 last updated April 22, 2024 at 12:30 PM EDT.

Q

Does Willow Biosciences (CANSF) pay a dividend?

A

There are no upcoming dividends for Willow Biosciences.

Q

When is Willow Biosciences (OTCQB:CANSF) reporting earnings?

A

Willow Biosciences does not have any upcoming earnings scheduled.

Q

Is Willow Biosciences (CANSF) going to split?

A

There is no upcoming split for Willow Biosciences.

Q

What sector and industry does Willow Biosciences (CANSF) operate in?

A

Willow Biosciences is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.